The outcomes of transcatheter aortic valve implantation (TAVI) have improved over years with rapid technological advances and growing experience of operators, however still several unexpected problems may occur during the procedure [1] [2] [3] . We present a case of patient with frozen leaflet phenomenon. Echocardiography demonstrated degenerated bioprosthesis with mean and max gradient -74 mmHg and 127 mmHg, respectively, mild regurgitation and ejection fraction of 50%. The patient underwent valvuloplasty of bioprosthesis 2 years before with temporary clinical improvement. After careful evaluation he was deemed to be at high surgical risk (EuroSCORE II 7,6%) and TAVI was recommended.
According to CT results ( Figure 1A ,S1) aortic annulus was 18,9 mm and with use of a Valvein-valve application a 23 mm Evolute R (Medtronic, USA) prosthesis was selected. The Ferrari E. [4] suggested two ways of treatment depending on the patient hemodynamicsin stable patient to control position of a stiff guidewire, to verify the valve shape and re-balloon in case of distortion and to increase the blood pressure to mobilize the frozen leaflet from the stent, while in unstableto implant a second prosthesis and to consider ECMO or femofemoral cardiopulmonary bypass to stabilize the patient.
There are only single reports of a frozen leaflet phenomenon. All describe implantation of the second prosthesis as a final rescue treatment. Eggebrecht el al. [5] presented two cases of severe regurgitation during valve-in-valve procedure, one of them with central flow through the prosthesis, also treated with second prosthesis implantation ("valve-in-valve-in-valve").
Frozen leaflef phenomenon in our patient was probably caused by anchoring of the prosthesis leaflet by the degenerated bioprosthesis. However in the presence of two already implanted narrow prostheses (a 20 mm Soprano Sorin and a 23 mm CoreValve Evolut R) next prosthesis implantation was deemed harmful. The mobilisation of the frozen leaflet with a pigtail occurred to be a rescue manouvere. We suggest that such simple attempt should be recommended in similar cases before the decision of implantation of the second valve.
Finally, it is worth to mention a problem of prosthesis-patient mismatch after valve-invalve TAVI in our patient. Currently, bioprosthetic valve fracture, a novel technique was developed to address this complication. Before or after implantation of the transcatheter prosthesis, a highpressure balloon inflation is performed to fracture the surgical sewing ring of the bioprosthesis. This procedure enables expansion of both prostheses, increasing the effective orifice area and improving the final result.
